ProCell introduces new device for blood conservation during surgery

11 June 2020 (Last Updated June 11th, 2020 11:57)

ProCell Surgical has launched a proprietary medical device ProCell to automate the manual activity of surgical sponge-blood recovery for intraoperative autotransfusion (IAT).

ProCell introduces new device for blood conservation during surgery
ProCell is designed to enable automated and more efficient blood collection process during surgery. Credit: Arek Socha / Pixabay.

ProCell Surgical has launched a proprietary medical device ProCell to automate the manual activity of surgical sponge-blood recovery for intraoperative autotransfusion (IAT).

The new device is designed to enable automated and more efficient blood collection process. Hand-wringing is considered to be a time-consuming process, which tends to vary depending on a person’s strength, technique and stamina.

The company said that ProCell will strengthen the hospital’s surgical blood conservation efforts during the surgery.

The device uses an operating room’s standard vacuum suction to apply a consistent compressive force to extract blood effectively from surgical sponges.

Through its own suction tubing, the recovered blood will be sent to the cell saver equipment where it is processed. It will be then re-infused into the patient in the course of the same surgical procedure.

IAT, which has been shown to reduce the requirements for donor blood transfusions during surgery, is routinely used in the operating room.

ProCell Surgical CEO and co-inventor of the device Robert Krensky said: “ProCell Surgical’s sponge-blood recovery system brings the first automated innovation for sponge-blood recovery directly to the operating room table.

“It is easy to operate and can be used repeatedly during its single-case use. ProCell essentially closes the technology gap that existed during this important preliminary phase of IAT.”

Commenting on the new development, ProCell Surgical COO Mike Kehoe said: “In my 30 plus years of managing medical device companies, this is the first product that I have been involved with that is not only cost-effective and proprietary but represents a generational paradigm shift in the approach to conservation of blood during surgery.”